The Effect of Intravenous Nalbuphine on PONV With Intrathecal Morphine in Abdominoplasty.

Assiut University80 enrolled

Overview

How effectively intravenous nalbuphine can reduce the incidence of PONV after intrathecal administration of morphine in abdominoplastic surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

Conditions

Abdominal Obesity

Interventions

Intrathecal MorphineDRUG

Group 1

Intrathecal Morphine + Intravenous NalbuphineDRUG

Group 2

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients undergoing abdominoplasty under spinal anesthesia * American Society of Anesthesiologists (ASA) class I and II. Exclusion Criteria: * allergy to local anesthetics * bleeding diatheses * local infection or sepsis

Locations (1)

Assiut University Hospital

Asyut, Egypt

RECRUITING

Outcomes

Primary Outcomes

postoperative nausea and vomiting

A verbal descriptive scale (VDS) was used to assess the severity of PONV. ( no nausea=0, severe nausea= 10) by postoperative nausea and vomiting scale which range (o no nasuea to 10 sever vomating). A verbal descriptive scale (VDS) was used to assess the severity of PONV .

Time frame: 24 hours

Secondary Outcomes

postoperative pain and puririts.

Visual analogue scale (VAS) pain scores (no pain = 0, worst possible pain = 10).

Time frame: 24 hours

Central Contacts

Mohamed Bakri, Prof

CONTACT

+20882413201 mhbakri@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.